MnTE-2-PyP Attenuates TGF-β-Induced Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Inhibiting the Smad2/3 Signaling Pathway. (25th February 2019)
- Record Type:
- Journal Article
- Title:
- MnTE-2-PyP Attenuates TGF-β-Induced Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Inhibiting the Smad2/3 Signaling Pathway. (25th February 2019)
- Main Title:
- MnTE-2-PyP Attenuates TGF-β-Induced Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Inhibiting the Smad2/3 Signaling Pathway
- Authors:
- Yang, Yu
Zhang, Pei
Yan, Ruicheng
Wang, Qi
Fang, Erhu
Wu, Hongxue
Li, Shijun
Tan, Haiyan
Zhou, Xing
Ma, Xianxiong
Tang, Yu
Huang, Yongming
Deng, Rui
Liu, Ying
Tong, Shilun
Wang, Zhihua
Oberley-Deegan, Rebecca E.
Tong, Qiang - Other Names:
- Zielonka Jacek Academic Editor.
- Abstract:
- Abstract : Background . As a key step in enhancing cancer cell invasion and metastasis, epithelial-mesenchymal transition (EMT) plays an important role in colorectal cancer progression. EMT is triggered by a variety of signaling pathways, among which the transforming growth factor β (TGF- β ) signaling pathway has been implicated as a primary inducer. Accumulating evidence demonstrates that MnTE-2-PyP (chemical name: manganese(III) meso -tetrakis-(N-ethylpyridinium-2-yl), a superoxide dismutase (SOD) mimetic, inhibits TGF- β signaling; however, its ability to inhibit TGF- β -induced EMT in colorectal cancer has not yet been explored. Methods . To verify our hypothesis that MnTE-2-PyP attenuates TGF- β -induced EMT, human colorectal cancer cells were treated with TGF- β in the presence or absence of MnTE-2-PyP. Cells were analyzed by several techniques including western blotting, real-time quantitative PCR, transwell assay, and wound healing assay. Results . MnTE-2-PyP reverses cell phenotypes induced by TGF- β in colon cancer cells. MnTE-2-PyP treatment significantly reduced the expression of mesenchymal markers but maintained epithelial marker expression. Mechanistically, MnTE-2-PyP suppressed the phosphorylated Smad2/3 protein levels induced by TGF- β in SW480 cells, but MnTE-2-PyP failed to suppress TGF- β -induced Slug and Snail expression in colorectal cells. Furthermore, MnTE-2-PyP effectively suppressed TGF- β -mediated cell migration and invasion and the expressionAbstract : Background . As a key step in enhancing cancer cell invasion and metastasis, epithelial-mesenchymal transition (EMT) plays an important role in colorectal cancer progression. EMT is triggered by a variety of signaling pathways, among which the transforming growth factor β (TGF- β ) signaling pathway has been implicated as a primary inducer. Accumulating evidence demonstrates that MnTE-2-PyP (chemical name: manganese(III) meso -tetrakis-(N-ethylpyridinium-2-yl), a superoxide dismutase (SOD) mimetic, inhibits TGF- β signaling; however, its ability to inhibit TGF- β -induced EMT in colorectal cancer has not yet been explored. Methods . To verify our hypothesis that MnTE-2-PyP attenuates TGF- β -induced EMT, human colorectal cancer cells were treated with TGF- β in the presence or absence of MnTE-2-PyP. Cells were analyzed by several techniques including western blotting, real-time quantitative PCR, transwell assay, and wound healing assay. Results . MnTE-2-PyP reverses cell phenotypes induced by TGF- β in colon cancer cells. MnTE-2-PyP treatment significantly reduced the expression of mesenchymal markers but maintained epithelial marker expression. Mechanistically, MnTE-2-PyP suppressed the phosphorylated Smad2/3 protein levels induced by TGF- β in SW480 cells, but MnTE-2-PyP failed to suppress TGF- β -induced Slug and Snail expression in colorectal cells. Furthermore, MnTE-2-PyP effectively suppressed TGF- β -mediated cell migration and invasion and the expression of matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) in colorectal cells. Conclusion . Taken together, we provide an in-depth mechanism by which MnTE-2-PyP inhibits colorectal cancer progression, supporting an important role for MnTE-2-PyP as an effective and innovative antitumor agent to enhance treatment outcomes in colorectal cancer. … (more)
- Is Part Of:
- Oxidative medicine and cellular longevity. Volume 2019(2019)
- Journal:
- Oxidative medicine and cellular longevity
- Issue:
- Volume 2019(2019)
- Issue Display:
- Volume 2019, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 2019
- Issue:
- 2019
- Issue Sort Value:
- 2019-2019-2019-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-02-25
- Subjects:
- Oxidative stress -- Periodicals
Cells -- Aging -- Periodicals
Cells -- Aging
Oxidative stress
Oxidative Stress -- Periodicals
Cell Aging -- Periodicals
Periodicals
611.0181 - Journal URLs:
- https://www.hindawi.com/journals/omcl/ ↗
- DOI:
- 10.1155/2019/8639791 ↗
- Languages:
- English
- ISSNs:
- 1942-0900
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 10426.xml